- Home
- AVIR vs FSBW Comparison
AVIR vs FSBW Comparison
Compare AVIR & FSBW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVIR
- FSBW
- Stock Information
- Founded
- AVIR 2012
- FSBW 1936
- Country
- AVIR United States
- FSBW United States
- Employees
- AVIR N/A
- FSBW N/A
- Industry
- AVIR Medicinal Chemicals and Botanical Products
- FSBW Banks
- Sector
- AVIR Health Care
- FSBW Finance
- Exchange
- AVIR Nasdaq
- FSBW Nasdaq
- Market Cap
- AVIR 277.8M
- FSBW 324.8M
- IPO Year
- AVIR 2020
- FSBW 2012
- Fundamental
- Price
- AVIR $3.50
- FSBW $40.14
- Analyst Decision
- AVIR Hold
- FSBW Hold
- Analyst Count
- AVIR 1
- FSBW 1
- Target Price
- AVIR $6.00
- FSBW $44.00
- AVG Volume (30 Days)
- AVIR 361.0K
- FSBW 13.9K
- Earning Date
- AVIR 08-07-2025
- FSBW 07-22-2025
- Dividend Yield
- AVIR N/A
- FSBW 2.79%
- EPS Growth
- AVIR N/A
- FSBW N/A
- EPS
- AVIR N/A
- FSBW 4.15
- Revenue
- AVIR N/A
- FSBW $139,676,000.00
- Revenue This Year
- AVIR N/A
- FSBW $9.62
- Revenue Next Year
- AVIR N/A
- FSBW $5.35
- P/E Ratio
- AVIR N/A
- FSBW $9.66
- Revenue Growth
- AVIR N/A
- FSBW 0.61
- 52 Week Low
- AVIR $2.46
- FSBW $34.61
- 52 Week High
- AVIR $4.15
- FSBW $49.15
- Technical
- Relative Strength Index (RSI)
- AVIR 48.71
- FSBW 50.46
- Support Level
- AVIR $3.33
- FSBW $37.22
- Resistance Level
- AVIR $3.60
- FSBW $41.46
- Average True Range (ATR)
- AVIR 0.16
- FSBW 1.27
- MACD
- AVIR -0.02
- FSBW 0.15
- Stochastic Oscillator
- AVIR 26.69
- FSBW 72.15
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).
About FSBW FS Bancorp Inc.
FS Bancorp Inc is the holding company of 1st Security Bank, a diversified lender with a focus on the origination of commercial real estate, one-to-four-family, and home equity loans, consumer loans, including a variety of indirect home improvement (fixture secured loans), and marine loans, and commercial business loans. The company has two operating segments; The commercial and consumer banking segment provides diversified financial products and services to its commercial and consumer customers through Bank branches, automated teller machines, online banking platforms, mobile banking apps, and telephone banking; and The home lending segment originates one-to-four-family residential mortgage loans for sale in the secondary markets as well as loans held for investment.